10-K - VITASPRING BIOMEDICAL CO. LTD. (0001697884) (Filer)

Wall Street counts down to SpaceX IPO

Wall Street counts down to SpaceX IPO To display this content from YouTube, you must enable advertisement tracking and audience measurement. One of your browser extensions seems to be blocking the video player from loading. To watch this content, you may need to disable it on this site.

Oracle’s stock slides after earnings, as the steep price of AI spooks investors

Oracle blew past earnings expectations and grew its contract pipeline to $638 billion, but Wall Street is concerned about its rising AI costs.

Rollins Defends Screwworm Response as USDA Staff Cuts Draw Fire

Oracle beats on earnings, but stock drops on plans to raise another $20 billion

Oracle reported better-than-expected earnings and revenue for the fiscal fourth quarter on Wednesday while also raising its profit forecast for the year. The stock dropped 5% in extended trading as the company plans to raise more money to finance its AI buildout. Here's how the company did in comparison with LSEG consensus: - Earnings per share: $2.11 adjusted vs. $1.96 expected - Revenue: $19.18 billion vs. $19.10 billion expected Revenue increased 21% year over year in the quarter, which...